Inventor · disambiguated record
Hatsuo Kawada
Also filed as: KAWADA HATSUO
7 granted patents·6 pending applications·66 citations·filing 2007–2025
82Inventor score
Top patents by PatentIndex Score
13 records- 0192US9440922B2Tetracyclic compoundCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Sep 13, 2016·19 cites·34 claims
- 0289US9126931B2Tetracyclic compoundKINOSHITA KAZUTOMO·Filed 2010·Granted Sep 8, 2015·32 cites·29 claims
- 0382US8022205B2Pyrimidine derivatives as PI3K inhibitor and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2007·Granted Sep 20, 2011·11 cites·18 claims
- 0478US2023142119A1Tetracyclic compoundCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0575US12410212B2Cyclic compound having selective KRAS inhibitory effect on HRAS and NRASCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Sep 9, 2025·0 cites·24 claims
- 0671US10005739B2Quinazolinone and isoquinolinone derivativeCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted Jun 26, 2018·2 cites·10 claims
- 0770US9567304B2Quinazolinedione derivativeCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Granted Feb 14, 2017·2 cites·10 claims
- 0868US2022306578A1Tetracyclic compoundCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0963US2020017442A1Tetracyclic compoundCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1056US2016340308A1Tetracyclic compoundCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 1154US2025230193A1Cyclic compound having selective kras inhibitory effect on hras and nrasCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1252US2024158446A1Cyclic compound having selective inhibitory action on kras over hras and nrasCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1340US9695118B2Benzamide derivativeCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Granted Jul 4, 2017·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Hatsuo Kawada files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →